an increasing trendP = 0.192
Although the 5-year survival rate showed an increasing trend, a significant difference was not found between the chemotherapy groups and nonchemotherapy groups in the univariate analysis (57.9% vs.54.4%, P = 0.192).
Although the 5-year survival rate showed an increasing trend, a significant difference was not found between the chemotherapy groups and nonchemotherapy groups in the univariate analysis (57.9% vs.54.4%, P = 0.192).
In patients with TNM stage II-III disease, the results showed a trend that was consistent with that of the whole patient cohort; a higher Fib-Alb score was independently associated with worse survival (Fib-Alb score 1, HR: 1.38, 95% CI: 1.01-1.61; Fib-Alb score 2, HR: 1.56, 95% CI: 1.17-2.07) ( Figure 4(b) ).